MENU
NSRX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Nasus Pharma (NSRX) Earnings Date & Reports
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions... Show more
A.I. Advisor
published Earnings
NSRX is expected to report earnings to fall 39.47% to -23 cents per share on September 02
Q2'26
Est.
$-0.23
Q4'25
Beat
by $0.15
The last earnings report on February 25 showed earnings per share of -37 cents, beating the estimate of -52 cents. With 3.21K shares outstanding, the current market capitalization sits at 36.54M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information